Mineralys Therapeutics, Inc. MLYS Fair value of options outstanding
Fair value of options outstanding at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept mlys:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateFairValue.
The official record: Mineralys Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s fair value of options outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s fair value of options outstanding?
- Mineralys Therapeutics, Inc. (MLYS) reported fair value of options outstanding of $19.3M in Q4 2025.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s fair value of options outstanding?
- Over 3 years (2022 to 2025), Mineralys Therapeutics, Inc.'s fair value of options outstanding has grown at a 477.9% compound annual growth rate (CAGR), from $100K to $19.3M.
- What does fair value of options outstanding mean?
- This represents the total estimated fair value of stock options granted to employees and directors that remain outstanding. It reflects the company's commitment to long-term incentive alignment and the potential future dilution impact on existing shareholders.